• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Intravenous iron associated with increased infection risk compared to oral or no iron

byJake EngelandMichael Pratte
November 20, 2021
in Chronic Disease, Emergency, Hematology, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This systematic review and meta-analysis demonstrated that intravenous iron was associated with an increased risk of infection compared to oral or no iron.

2. Intravenous iron resulted in higher hemoglobin increases and reduced red blood transfusion risk, yet no change in mortality or length of hospital stay compared to oral or no iron.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Intravenous (IV) iron is recommended to treat anemia associated with chronic conditions, such as chronic kidney disease, inflammatory bowel disease, and heart failure. IV iron increases circulating non-transferrin-bound iron, which can promote pathogen growth and predispose patients to infection. Although IV iron has been shown to treat anemia effectively and reduce transfusion requirements, the risk of infection is unclear. This systematic review and meta-analysis examined the safety and effectiveness of IV iron compared with oral iron or no iron. The primary outcome was the risk of infection. A total of 162 studies with 40 066 participants were included (154 randomized clinical trials and 8 non-randomized studies) from 1966 to January 31, 2021. IV iron was associated with a higher risk of infection compared to oral or no iron (relative risk [RR]: 1.17 [95% CI: 1.04-1.31]; I2= 37%; p= 0.03), which equates to 17 additional infections for every 1000 patients (95% CI: 4-31) who receive IV iron. Among secondary outcomes, IV iron was associated with increase in hemoglobin (mean difference [MD]: 5.7g/L [95%: 0.50-0.64]; I2= 94%; p<0.001) and a reduction in the risk of requiring red blood cell transfusions (RR: 0.93 [95% CI: 0.76-0.89]; I2= 15%; p<0.001) compared to oral iron or no iron. Importantly, there was no significant difference in long-term mortality (RR: 0.94 [95% CI: 0.75-1.18]; I2= 0%; p= 0.63) or length of hospital stay (MD: -0.43 days [95% CI: -1.10 to 0.24]; I2= 50%; p= 0.05) with IV iron compared to oral or no iron. Overall, IV iron was associated with increased infection risk, although it was more effective in improving hemoglobin levels and reducing transfusions. This was a large, strong meta-analysis of many randomized, controlled trials with strict methodological criteria. Notably, however, there were variations in infection reporting and criteria between the included studies. It is critical to consider the benefits (hemoglobin and transfusions) and risks (infection) when deciding between iron treatments for anemic patients.

Click to read the study in JAMA Network Open

Click to read an accompanying editorial in JAMA Network Open

Relevant Reading: Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomized clinical trial

RELATED REPORTS

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anemiaintravenous ironironiron deficiency
Previous Post

Pre-treatment and post-treatment factors may explain discrepancies between functional outcomes and follow-up imaging infarct volume after acute ischemic stroke

Next Post

2 Minute Medicine Rewind November 15, 2021

RelatedReports

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia
StudyGraphics

#VisualAbstract: Canakinumab treatment did not reduce pain to clinical significance but shows anti-inflammatory effects in children and young adults with sickle cell anemia

May 4, 2022
#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis
StudyGraphics

#VisualAbstract: Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis

April 14, 2022
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

April 8, 2022
#VisualAbstract: Moderate-dose hydroxyurea does not decrease stroke incidence but may lower hospitalization rates in children with sickle cell anaemia, compared to low-dose hydroxyurea
StudyGraphics

#VisualAbstract: Moderate-dose hydroxyurea does not decrease stroke incidence but may lower hospitalization rates in children with sickle cell anaemia, compared to low-dose hydroxyurea

January 13, 2022
Next Post
Significant number of wrong-patient errors in radiology reports

2 Minute Medicine Rewind November 15, 2021

American Academy of Pediatrics recommends standards for adverse event disclosures

Cognitive-behavioural therapy alternating between face-to-face and online module sessions effective for treating anxiety disorders

USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy

Maternal genetic risk of hypertension associated with reduced placental weight

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.